TABLE 1.
Tissue and/or cell type | Mutation | Reference(s) |
---|---|---|
Lung cancer tissue and cell lines | Genetic mutation, hypermethylation leading to downregulation of CHFR expression | 23, 77 |
Esophageal primary cancer and cell lines | Hypermethylation | 78, 110 |
Gastric cancer and cell lines | Hypermethylation | 51, 52, 60, 78 |
Brain tumors | Hypermethylation | 23 |
Bone tumors | Hypermethylation | 23 |
Colorectal cancers and adenomas | Hypermethylation | 23, 127 |
Head and neck cancers | Hypermethylation | 127 |
Breast cancer cells | Hypermethylation | 30 |
Gallbladder carcinomas | Hypermethylation | 119 |
T-cell lymphoma | Hypermethylation | 132 |
Nasopharyngeal carcinomas | Hypermethylation | 21 |
Hepatocellular carcinoma | Hypermethylation | 108 |
Malignant peripheral nerve sheath tumors | Reduced expression | 64 |
Endometrial cancer | Hypermethylation | 139 |